Post Training Evaluation

Thank you for attending this learning activity.  Please take a few moments to evaluation this training.
IMPORTANT!!
Once you complete the post-training evaluation and click FINISHED and you will be redirected to a webpage to print or save your continuing education certificate.
If you have difficulties completing this survey, contact Amy Wales at amy.wales@miccsi.org.

Demographics

Question Title

* 1. Personal Information

Question Title

* 3. Please choose your role:

Question Title

* 4. After attending this session, please indicate your confidence in having conversations with patients regarding cannabis use.

Question Title

* 5. On a scale of 1-5, how would you rate this training overall? (Scale: 1=very dissatifed & 5=very satisfied)

Question Title

* 6. What did you like most about this session?

Question Title

* 7. What did you like least about this session?

Question Title

* 8. Do you have specific suggestions as to how this learning activity might be improved?

Question Title

* 9. Did you feel the content was:

Question Title

* 10. Please provide your impressions about Kevin Boehnke's presentation by rating each category on a scale of 1-5 where:

1=VERY POOR
2=POOR
3=AVERAGE
4=GOOD
5=EXCELLENT

  1 2 3 4 5
Knowledge of presenter
Overall rating of topic/presentation
This topic was relevant to my role

Question Title

* 11. Did the presentations and materials meet the following objective?
       1. Provide a high-level overview of how cannabinoids interact with the body, including risks, benefits, and ways that these compounds are often consumed.

Question Title

* 12. After attending this session, do you intend to change your practice behavior?

Question Title

* 13. After attending this session, I have the ability to apply the skills learned in my role.

Question Title

* 14. What new abilities/strategies have you gained from this training?

Question Title

* 15. Was the information/material presented in this learning activity free from commercial bias?

Question Title

* 16. If you answered no to the above question, please explain.

Question Title

* 17. Additional Comments:

T